QA: Viracta Therapeutics Inc in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001061027_2015_Viracta_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001061027, Viracta Therapeutics Inc

  xvar xval
0 AssetsCurrent 44,204,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 42,000
3 remainder_Assets 0
4 LiabilitiesCurrent 27,881,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 31,263,333
9 ResearchAndDevelopmentExpense 27,218,328
10 remainder_Expenses 1,503,090
11 remainder_Revenues 6,461,394
12 remainder_NetIncome 2,373,320
13 remainder_ComprehensiveNetIncome -14,006
  yvar yval
0 Assets 44,246,000
1 Liabilities 27,881,000
2 Expenses 59,984,751
3 Revenues 6,461,394
4 StockholdersEquity 16,365,000
5 NetIncome -51,150,037
6 ComprehensiveNetIncome -51,157,040
7 BaseVar 70,480,236
8 EconomicCapitalRatiobeforeLimitedLiability -0.429
9 EconomicCapitalRatio 1.39

Edgar->Model Mapping

Feature Distribution

Change over Time